Security readout for executives and security teams
This flaw affects Hospira LifeCare PCA infusion systems before version 7.0. The device may accept unvalidated network traffic for drug libraries, software updates, or configuration changes, creating a patient-safety and operational risk if an attacker can reach exposed services. Exposure is most relevant in healthcare environments running Hospira LifeCare PCA systems before 7.0, especially where device networks are reachable from broader hospital, vendor, or untrusted networks. Treat this as high priority for hospitals using these pumps. The main concern is unauthorized modification of medication or device settings, not broad IT compromise. Prioritize inventory, isolation, and vendor-confirmed remediation. Mitigation focus: Identify all Hospira LifeCare PCA systems and their software versions.; Check Hospira, FDA, and CISA guidance for approved update or mitigation steps.; Restrict access to TELNET, HTTP, HTTPS, and UPNP services where clinically safe..
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-345: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2014-5406 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- High
- CVSS
- 7.6 (2.0)
- Known Exploited
- No
- Published
Vector: AV:N/AC:H/Au:N/C:C/I:C/A:C
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
AV:N/AC:H/Au:N/C:C/I:C/A:C4.910Primary CVE scoreVulnerability scoring details
Base CVSS 2.0 score
7.6HighVector: AV:N/AC:H/Au:N/C:C/I:C/A:C
Source materials
- CVE List V5 sourceCVE List V5
- https://www.cisa.gov/news-events/ics-advisories/icsa-15-125-01CVE reference
- https://xs-sniper.com/blog/2015/06/08/hospira-plum-a-infusion-pump-vulnerabilities/CVE reference · x_refsource_MISC
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2015/icsa-15-125-01.jsonCVE reference
- https://ics-cert.us-cert.gov/advisories/ICSA-15-125-01CVE reference · x_refsource_MISC, x_transferred
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Insufficient Verification of Data Authenticity
Insufficient Verification of Data Authenticity represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.